Cargando...
Screening for Prostate Cancer in the US? Reduce the harms and keep the benefit
While the benefit of prostate specific antigen (PSA) based screening is uncertain, a significant proportion of screen-detected cases is overdiagnosed. In order to make screening worthwhile, it is necessary to find policies that minimize overdiagnosis, without significantly increasing prostate cancer...
Gardado en:
| Publicado en: | Int J Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452024/ https://ncbi.nlm.nih.gov/pubmed/25123412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29136 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|